These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 21934201

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression.
    Zhu J, Feng A, Sun J, Jiang Z, Zhang G, Wang K, Hu S, Qu X.
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1519-26. PubMed ID: 21557772
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Increased frequency of CD4+CD25(high)FoxP3+ regulatory T cells in patients with hepatocellular carcinoma.
    Feng X, Li B, Ye H, Long D.
    Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):309-14. PubMed ID: 21633918
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The presence and the significance of CD4+CD25+ regulatory T cells in livers of patients with hepatocellular carcinoma].
    Yang XH, Liu BR, Jiang HC.
    Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):279-82. PubMed ID: 17456316
    [Abstract] [Full Text] [Related]

  • 9. Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients.
    Yang ZQ, Yang ZY, Zhang LD, Ping-Bie, Wang SG, Ma KS, Li XW, Dong JH.
    Hum Immunol; 2010 Dec; 71(12):1180-6. PubMed ID: 20870003
    [Abstract] [Full Text] [Related]

  • 10. [The frequency, phenotypes and functions of CD4+ CD25+ regulatory T cells in hepatocellular carcinoma patients].
    Zhang HH, Fei R, Mei MH, Liao WJ, Wang XY, Cong X, Qin LL, Ji Y, Wang SX, Wei L, Chen HS.
    Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):266-72. PubMed ID: 17456313
    [Abstract] [Full Text] [Related]

  • 11. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma.
    Ormandy LA, Hillemann T, Wedemeyer H, Manns MP, Greten TF, Korangy F.
    Cancer Res; 2005 Mar 15; 65(6):2457-64. PubMed ID: 15781662
    [Abstract] [Full Text] [Related]

  • 12. Foxp3+ regulatory T cells are associated with the natural history of chronic hepatitis B and poor prognosis of hepatocellular carcinoma.
    Wang F, Jing X, Li G, Wang T, Yang B, Zhu Z, Gao Y, Zhang Q, Yang Y, Wang Y, Wang P, Du Z.
    Liver Int; 2012 Apr 15; 32(4):644-55. PubMed ID: 22118340
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical prognostic value of CD4+CD25+FOXP3+regulatory T cells in peripheral blood of Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma patients.
    Li F, Guo Z, Lizée G, Yu H, Wang H, Si T.
    Clin Chem Lab Med; 2014 Sep 15; 52(9):1357-65. PubMed ID: 24646790
    [Abstract] [Full Text] [Related]

  • 15. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
    Kakita N, Kanto T, Itose I, Kuroda S, Inoue M, Matsubara T, Higashitani K, Miyazaki M, Sakakibara M, Hiramatsu N, Takehara T, Kasahara A, Hayashi N.
    Int J Cancer; 2012 Dec 01; 131(11):2573-83. PubMed ID: 22419479
    [Abstract] [Full Text] [Related]

  • 16. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
    Unitt E, Rushbrook SM, Marshall A, Davies S, Gibbs P, Morris LS, Coleman N, Alexander GJ.
    Hepatology; 2005 Apr 01; 41(4):722-30. PubMed ID: 15791620
    [Abstract] [Full Text] [Related]

  • 17. The impact of CD4+ CD25+ T cells in the tumor microenvironment of hepatocellular carcinoma.
    Lee WC, Wu TJ, Chou HS, Yu MC, Hsu PY, Hsu HY, Wang CC.
    Surgery; 2012 Feb 01; 151(2):213-22. PubMed ID: 21975289
    [Abstract] [Full Text] [Related]

  • 18. Intrahepatic interleukin-17+ T cells and FoxP3+ regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma.
    Huang Y, Wang F, Wang Y, Zhu Z, Gao Y, Ma Z, Xu R, Du Z.
    J Gastroenterol Hepatol; 2014 Apr 01; 29(4):851-9. PubMed ID: 24303990
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Role of Foxp3-positive tumor-infiltrating lymphocytes in the histologic features and clinical outcomes of hepatocellular carcinoma.
    Mathai AM, Kapadia MJ, Alexander J, Kernochan LE, Swanson PE, Yeh MM.
    Am J Surg Pathol; 2012 Jul 01; 36(7):980-6. PubMed ID: 22446942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.